By Nick Lavars June 02, 2021 An artist’s impression of a cancer cellGiovanni_Cancemi/Depositphotos Leveraging a newfound ability to identify the “fittest” metastatic cancer cells, scientists at the UK’s University of Salford have discovered that an already approved drug can be deployed to cut off their fuel supply, while leaving normal healthy cells unharmed. Metastatic cancer...
by University of Florida Medical illustration of drug-resistant Mycobacterium tuberculosis. Credit: CDC Public Health Image Library Tuberculosis is an age-old respiratory scourge, with a new twist: growing resistance to multiple first- and second-line drugs. UF researchers and physicians report on using a novel treatment to slash treatment time—and cure—a patient with extensively drug-resistant TB. Physicians and...
Valerie Mizrahi & Clifton E. Barry III The 2017 Nobel Prize in Chemistry was awarded for the development of an imaging method called cryo-electron microscopy. On bestowing the prize, the Royal Swedish Academy of Sciences stated that this technique has “moved biochemistry into a new era”. Writing in Nature, Guo et al.1 provide a compelling glimpse into this new...
by University of Birmingham A new study led by scientists at the University of Birmingham has shed fresh light on how a key front-line drug kills the tuberculosis bacterium. The research paves the way for development of new antibiotic drugs targeted at emerging strains of TB. Tuberculosis (TB) remains a global health challenge, responsible for...
An antibiotic used to treat tuberculosis has the potential to alleviate the social impairments associated with autism spectrum disorder, new research suggests. Researchers suggest that the social impairments seen in autism could be treated with an antibiotic. The study reveals that the drug d-cycloserine boosted the function of an autism-related gene called PCDH10 and...
